Middle East and Africa Psychedelic Drugs Market – Industry Trends and Forecast to 2029

Запрос на TOC Запрос на TOC Обратиться к аналитику Обратиться к аналитику Купить сейчас Купить сейчас Узнать перед покупкой Узнать перед покупкой Бесплатный пример отчета Бесплатный пример отчета

Middle East and Africa Psychedelic Drugs Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Published Report
  • Jun 2022
  • MEA
  • 350 Pages
  • Количество таблиц: 84
  • Количество рисунков: 52

Middle East And Africa Psychedelic Drugs Market

Размер рынка в млрд долларов США

CAGR :  % Diagram

Diagram Прогнозируемый период
2022 –2029
Diagram Размер рынка (базовый год)
USD 12.14 Million
Diagram Размер рынка (прогнозируемый год)
USD 27.94 Million
Diagram CAGR
%
Diagram Основные игроки рынка
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>Middle East and Africa Psychedelic Drugs Market, By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) Industry Trends and Forecast to 2029

Рынок психоделических препаратов на Ближнем Востоке и в Африке

Middle East and Africa Psychedelic Drugs Market Analysis and Insights

Psychedelic drugs involve various types of chemical substances including lysergic acid diethylamide (LSD) and chemical extracted from plants. These drugs have the ability to change or enhance the sensory perceptions, thought processes, energy levels and have also been reported to facilitate spiritual experiences.

Рынок психоделических препаратов

Рынок психоделических препаратов

The psychedelic drugs can be categorized into empathogens and dissociative drugs (such as phenylcyclohexyl piperidine (PCP)) and serotonergic (classic hallucinogens) such as LSD. Both types of psychedelic drugs can cause hallucinations and feeling of sensation, moreover, dissociative drugs can make a person to fell out of control from their body or environment and makes them feel disconnected. Based on the source, psychedelic drugs have been categorized under natural and synthetic types.

These drugs have wide applications in the treatment of major depressive disorder, post-traumatic stress disorder, panic disorder, treatment-resistant depression and opiate addiction among others. Psychedelic drugs are also known by several other names such as lysergic acid derivative (LSD) which are also known as blotter, dots, sugar, acid, trips and window pane, ketamine are also known as vitamin K, bump, green, K/special K, purple and super acid, PCP are also known as angel/angel dust, boat/love boat, peace, killer weed, super grass and ozone.

Middle East and Africa market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 11.1% in the forecast period of 2022 to 2029 and is expected to reach USD 27.94 million by 2029 from USD 12.14 million in 2021.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019-2014)

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)

Countries Covered

South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa

Market Players Covered

The major companies which are dealing in the market are Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.), Hikma Pharmaceuticals PLC, Pfizer Inc., F. Hoffmann-La Roche Ltd, among others

Market Definition

Psychedelic drugs involve various types of chemical substances including lysergic acid diethylamide (LSD) and chemical extracted from plants. These drugs have the ability to change or enhance the sensory perceptions, thought processes, energy levels and have also been reported to facilitate spiritual experiences.

The psychedelic drugs can be categorized into empathogens and dissociative drugs (such as phenylcyclohexyl piperidine (PCP)) and serotonergic (classic hallucinogens) such as LSD. Both types of psychedelic drugs can cause hallucinations and feeling of sensation, moreover, dissociative drugs can make a person to fell out of control from their body or environment and makes them feel disconnected. Based on the source, psychedelic drugs have been categorized under natural and synthetic types.

These drugs have wide applications in the treatment of major depressive disorder, post-traumatic stress disorder, panic disorder, treatment-resistant depression and opiate addiction among others. Psychedelic drugs are also known by several other names such as lysergic acid derivative (LSD) which are also known as blotter, dots, sugar, acid, trips and window pane, ketamine are also known as vitamin K, bump, green, K/special K, purple and super acid, PCP are also known as angel/angel dust, boat/love boat, peace, killer weed, super grass and ozone.

Psychedelic Drugs Market Dynamics

Drivers

  • Growing Acceptance Of Psychedelic Drugs For Treating Depression

Psychedelics have achieved a large popularity within the last decade as are familiarly involved with human mental healing and treatment practices and have the power of mind- healing. The growing researchers and scientist are exploring psychedelic drugs therapeutic value and compounds which could be a new treatment option for people with depression. Continuous research and development in the psychedelic drugs has increased the acceptance of psychedelics medication. Psychedelic drugs promising outcomes have increased the usage of psychedelic drugs across the South Africa and other regions which leads to increasing demand for psychedelic drugs, hence these factors are expected to act as drivers for the growth of the market.

  • Increasing Prevalence Of Depression And Mental Disorders

Mental disorders (or mental illnesses) affects persons feeling, mood, thinking, and behaviour and can be long-lasting (chronic) or occasional. Depression and mental disorders have the ability to affect individual’s capacity by virtue of which they perform their everyday tasks. There are numerous dissimilar types of mental disorders. Depression and mental disorders have increased globally due to various factors including family history and genes, abuse or stress, biological factors, usage of alcohol or recreational drugs and many others.

Additionally, increasing consumption of illicit substances has increased depression and mental disorders. Thus, increasing prevalence of depression and mental disorders are increasing the demand for psychedelic drugs which is expected to act as driver for the growth of the market.

  • Rising Awareness Towards Mental Health

As mental illness has adversely impacted the people ability to carry out normal functions of their life, this has become important to create awareness among people regarding the different types of cause, disorders it leads to and the treatment options available in the market in order to cure such life-devastating illness. In order to raise awareness several organizations and companies are launching campaigns and adoption initiatives. This in turn allows patients to opt for effective treatment option as per the disease cause and reported symptoms. Advertisements, awareness campaigns, and others have increased the awareness for psychedelic drugs. The awareness campaigns have encouraged people to select appropriate treatment for mental disorders procedures and professionals which is increasing the demand of psychedelic drugs. For this reason, rising awareness towards mental health is expected to act as driver for the market growth.

Opportunity

  • Increasing R&D Activities In Psychedelic Drugs

Psychedelic plants and fungi have been used in indigenous medicinal traditions for millennia. New psychedelic drugs development research has initiated by Albert Hofmann in 1938. He has synthesized the first lysergic acid diethylamide (LSD-25) and now recognized as the first person to ingest LSD after five years later. Hofmann was unaware of the significant effects and actions posed by that product. After a growing period of cultural and scientific exploration in the 1950s and 60s, psychedelic drug development research was slackened to a near halt. Increasing research and development expenditure in the psychedelic drugs is creating new opportunities in the market. Thus, increasing R&D activities in psychedelic drugs are acting as an opportunity for the growth of the market.

Also, the strategic initiatives taken by key market players will provide structural integrity and future opportunities for the psychedelic drugs market in the forecast period of 2022-2029.

Restraint/Challenge

  • High Cost Of Psychedelic Drugs

However, the high cost associated with psychedelic drugs will impede the growth rate of psychedelic drugs market. Additionally, stringent rules and regulations will further challenge the market in the forecast period mentioned above.

This psychedelic drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more information on psychedelic drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post COVID-19 Impact on psychedelic drugs market

The COVID-19 has positively affected the market. Lockdowns and isolation during pandemics complicate the disease management and medication adherence. Hence the use of various treatment drugs have widely increased in the world’s population. Hence, the pandemic has effected positively on this market.

Recent Development

  • In August 2020, Janssen Pharmaceuticals, Inc. received approval for its Spravato nasal spray indicated for treatment of suicidal people. As approximately 11% to 12% of Americans suffers from major depressive disorder that led them to commit suicide, this approval provided these patients with a remarkable therapy and paved the way for the company to generate more revenue.

Middle East and Africa Market Scope

Middle East and Africa psychedelic drugs market is segmented into source, type, drugs, application, route of administration, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Source

  • Synthetic
  • Natural

On the basis of source, the Middle East and Africa psychedelic drugs market is segmented into synthetic and natural.

Type

  • Empathogens
  • Dissociatives
  • Others

On the basis of type, the Middle East and Africa psychedelic drugs market is segmented into empathogens, dissociatives, and others.

Drugs

  • Gamma-Hydroxybutyric Acid
  • Ketamine
  • Psilocybin
  • Others

On the basis of drugs, the Middle East and Africa psychedelic drugs market is segmented into gamma-hydroxybutyric acid, ketamine, psilocybin and others.

.Application

  • Narcolepsy,
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • Opiate Addiction
  • Post-Traumatic Stress Disorder
  • Others

On the basis of application, the Middle East and Africa psychedelic drugs market is segmented into narcolepsy, treatment resistant depression, major depressive disorder, opiate addiction, post-traumatic stress disorder and others.

Route of Administration

  • Oral
  • Inhalation
  • Injectable

On the basis of route of administration, the Middle East and Africa psychedelic drugs market is segmented into oral, inhalation, injectable.

End User

  • Hospital
  • Specialty Clinics
  • Homecare
  • Others

On the basis of end user, the Middle East and Africa psychedelic drugs market is segmented into hospital, specialty clinics, homecare, and others.

Distribution Channel

  • Hospitals Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Рынок психоделических препаратов

On the basis of distribution channel, the Middle East and Africa psychedelic drugs market is segmented into hospitals pharmacy, retail pharmacy and online pharmacy.

Psychedelic drugs Market Regional Analysis/Insights            

The psychedelic drugs market is analysed and market size insights and trends are provided by country, source, type, drugs, application, route of administration, end user and distribution channel as referenced above.

The countries covered in this report are South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa.

Saudi Arabia country in the Middle East and Africa dominates the psychedelic drugs market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to ongoing clinical trials in the region and rapid research development is boosting the market.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Psychedelic Drugs Market Share Analysis

The psychedelic drugs market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on psychedelic drugs market.

Some of the major players operating in the psychedelic drugs market are Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.), Hikma Pharmaceuticals PLC, Pfizer Inc., F. Hoffmann-La Roche Ltd, among others.

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Middle East and Africa vs. Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry

Customization Available

Data Bridge Market Research — лидер в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их цели. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам требуются данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых необработанных файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Интерактивная панель анализа данных
  • Панель анализа компании для возможностей с высоким потенциалом роста
  • Доступ аналитика-исследователя для настройки и запросов
  • Анализ конкурентов с помощью интерактивной панели
  • Последние новости, обновления и анализ тенденций
  • Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Запросить демонстрацию

Содержание

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET END USER COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

4.1 PIPELINE ANALYSIS

4.2 PESTEL ANALYSIS

4.3 PORTER'S FIVE FORCES MODEL

5 REGULATORY FRAMEWORK: MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET

5.1 REGULATORY SCENARIO IN THE U.S.

5.2 REGULATORY SCENARIO IN THE U.K.

5.3 REGULATORY SCENARIO IN INDIA

5.4 REGULATORY SCENARIO IN UAE

5.5 REGULATORY SCENARIO IN AFRICA

5.6 REGULATORY SCENARIO IN BRAZIL

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 GROWING ACCEPTANCE OF PSYCHEDELIC DRUGS TO TREAT DEPRESSION

6.1.2 INCREASING PREVALENCE OF DEPRESSION AND MENTAL DISORDERS

6.1.3 RISING AWARENESS TOWARD MENTAL HEALTH

6.1.4 ONGOING CLINICAL TRIALS

6.1.5 RISE IN PRODUCT APPROVALS

6.2 RESTRAINTS

6.2.1 STRINGENT REGULATIONS FOR PSYCHEDELIC DRUGS

6.2.2 HIGH COST OF PSYCHEDELIC DRUGS

6.2.3 PATENT EXPIRY OF PSYCHEDELIC DRUGS

6.3 OPPORTUNITIES

6.3.1 INCREASING R&D ACTIVITIES IN PSYCHEDELIC DRUGS

6.3.2 BREAKTHROUGH THERAPY DESIGNATION BY REGULATORY AUTHORITY

6.3.3 UPCOMING REHABILITATION CENTERS

6.3.4 AVAILABILITY OF CERTIFIED HEALTHCARE PROFESSIONALS

6.4 CHALLENGES

6.4.1 SIDE EFFECTS ASSOCIATED WITH PSYCHEDELIC DRUGS

6.4.2 RISE IN ILLEGAL ALTERNATIVES

6.4.3 AVAILABILITY OF OTHER TREATMENT OPTIONS

7 COVID-19 IMPACT ON THE MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET

7.1 IMPACT ON PRICE

7.2 IMPACT ON DEMAND

7.3 IMPACT ON SUPPLY CHAIN

7.4 STRATEGIC DECISIONS FOR MANUFACTURERS

7.5 CONCLUSION

8 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE

8.1 OVERVIEW

8.2 EMPATHOGENS

8.3 DISSOCIATIVES

8.4 OTHERS

9 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE

9.1 OVERVIEW

9.2 SYNTHETIC

9.3 NATURAL

10 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS

10.1 OVERVIEW

10.2 GAMMA-HYDROXYBUTYRIC ACID

10.3 KETAMINE

10.4 PSILOCYBIN

10.5 OTHERS

11 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 NARCOLEPSY

11.3 TREATMENT RESISTANT DEPRESSION

11.4 MAJOR DEPRESSIVE DISORDER

11.5 OPIATE ADDICTION

11.6 POST-TRAUMATIC STRESS DISORDER

11.7 OTHERS

12 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION

12.1 OVERVIEW

12.2 ORAL

12.3 INHALATION

12.4 INJECTABLE

13 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER

13.1 OVERVIEW

13.2 HOSPITALS

13.3 SPECIALTY CLINICS

13.4 HOMECARE

13.5 OTHERS

14 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW

14.2 HOSPITALS PHARMACY

14.3 RETAIL PHARMACY

14.4 ONLINE PHARMACY

15 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY REGION

15.1 MIDDLE EAST & AFRICA

15.1.1 SAUDI ARABIA

15.1.2 ISRAEL

15.1.3 EGYPT

15.1.4 UAE

15.1.5 SOUTH AFRICA

16 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

17 SWOT ANALYSIS

18 COMPANY PROFILE

18.1 JAZZ PHARMACEUTICALS, INC.

18.1.1 COMPANY SNAPSHOT

18.1.2 REVENUE ANALYSIS

18.1.3 COMPANY SHARE ANALYSIS

18.1.4 PRODUCT PORTFOLIO

18.1.5 RECENT DEVELOPMENTS

18.2 PFIZER INC.

18.2.1 COMPANY SNAPSHOT

18.2.2 REVENUE ANALYSIS

18.2.3 COMPANY SHARE ANALYSIS

18.2.4 PRODUCT PORTFOLIO

18.2.5 RECENT DEVELOPMENTS

18.3 F. HOFFMANN- LA ROCHE LTD

18.3.1 COMPANY SNAPSHOT

18.3.2 REVENUE ANALYSIS

18.3.3 COMPANY SHARE ANALYSIS

18.3.4 PRODUCT PORTFOLIO

18.3.5 RECENT DEVELOPMENT

18.4 JANSSEN MIDDLE EAST & AFRICA SERVICES, LLC (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)

18.4.1 COMPANY SNAPSHOT

18.4.2 COMPANY SHARE ANALYSIS

18.4.3 PRODUCT PORTFOLIO

18.4.4 RECENT DEVELOPMENT

18.5 AVADEL

18.5.1 COMPANY SNAPSHOT

18.5.2 PRODUCT PORTFOLIO

18.5.3 RECENT DEVELOPMENT

18.6 CELON PHARMA SA

18.6.1 COMPANY SNAPSHOT

18.6.2 PRODUCT PORTFOLIO

18.6.3 RECENT DEVELOPMENT

18.7 COMPASS

18.7.1 COMPANY SNAPSHOT

18.7.2 PRODUCT PORTFOLIO

18.7.3 RECENT DEVELOPMENTS

18.8 CYBIN CORP.

18.8.1 COMPANY SNAPSHOT

18.8.2 PRODUCT PORTFOLIO

18.8.3 RECENT DEVELOPMENTS

18.9 ENTHEON BIOMEDICAL CORP

18.9.1 COMPANY SNAPSHOT

18.9.2 PRODUCT PORTFOLIO

18.9.3 RECENT DEVELOPMENT

18.1 GH RESEARCH

18.10.1 COMPANY SNAPSHOT

18.10.2 PRODUCT PORTFOLIO

18.10.3 RECENT DEVELOPMENT

18.11 HIKMA PHARMACEUTICALS PLC

18.11.1 COMPANY SNAPSHOT

18.11.2 REVENUE ANALYSIS

18.11.3 PRODUCT PORTFOLIO

18.11.4 RECENT DEVELOPMENTS

18.12 NRX PHARMACEUTICALS, INC.

18.12.1 COMPANY SNAPSHOT

18.12.2 PRODUCT PORTFOLIO

18.12.3 RECENT DEVELOPMENT

18.13 PHARMATHER HOLDINGS LTD.

18.13.1 COMPANY SNAPSHOT

18.13.2 PRODUCT PORTFOLIO

18.13.3 RECENT DEVELOPMENT

18.14 VERRIAN

18.14.1 COMPANY SNAPSHOT

18.14.2 PRODUCT PORTFOLIO

18.14.3 RECENT DEVELOPMENT

18.15 USONAINSTITUTE.ORG

18.15.1 COMPANY SNAPSHOT

18.15.2 PRODUCT PORTFOLIO

18.15.3 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

Список таблиц

TABLE 1 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, PIPELINE ANALYSIS

TABLE 2 PSYCHEDELICS RESEARCH STUDIES, IN EUROPE

TABLE 3 MENTAL ILLNESS IN THE U.S. ADULTS, IN 2020

TABLE 4 MENTAL DISORDERS, IN THE U.S. ADULTS, IN 2020

TABLE 5 DRUG DEVELOPMENT PATHWAY FOR FDA APPROVAL OF NEW MEDICATIONS

TABLE 6 THE 1971 UN CONVENTION ON PSYCHOTROPIC SUBSTANCES

TABLE 7 MAGIC MUSHROOMS PRICES FOR RESEARCHERS, IN THE U.S.

TABLE 8 COST OF PSYCHEDELIC DRUGS

TABLE 9 PSYCHEDELIC DRUGS R&D ACTIVITIES

TABLE 10 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA EMPATHOGENS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA DISSOCIATIVES IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA SYNTHETIC IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA NATURAL IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA GAMMA-HYDROXYBUTYRIC ACID IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA KETAMINE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA PSILOCYBIN IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA NARCOLEPSY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA TREATMENT RESISTANT DEPRESSION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA MAJOR DEPRESSIVE DISORDER IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA OPIATE ADDICTION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA POST-TRAUMATIC STRESS DISORDER IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA ORAL IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA INHALATION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA INJECTABLE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA HOSPITALS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA SPECIALTY CLINICS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA HOMECARE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA HOSPITALS PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA RETAIL PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA ONLINE PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 47 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 50 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 51 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 52 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 53 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 54 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 55 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 56 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 57 ISRAEL PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 58 ISRAEL PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 59 ISRAEL PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 60 ISRAEL PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 61 ISRAEL PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 62 ISRAEL PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 63 ISRAEL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 64 EGYPT PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 65 EGYPT PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 66 EGYPT PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 67 EGYPT PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 68 EGYPT PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 69 EGYPT PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 70 EGYPT PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 71 UAE PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 72 UAE PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 73 UAE PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 74 UAE PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 75 UAE PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 76 UAE PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 77 UAE PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 78 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 79 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 80 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 81 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 82 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 83 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 84 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

Список рисунков

FIGURE 1 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET : DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: MULTIVARIATE MODELLING

FIGURE 7 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: END USER COVERAGE GRID

FIGURE 10 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: SEGMENTATION

FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 13 RISING AWARENESS TOWARDS MERANTAL HEALTH DRIVING THE MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 14 EMPATHOGENS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET IN 2022 & 2029

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET

FIGURE 16 MENTAL ILLNESS AMONG THE U.S. ADULTS, IN 2020, (IN %), BY DEMOGRAPHIC GROUPS

FIGURE 17 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS, IN 2020, (IN %), BY DEMOGRAPHIC GROUPS

FIGURE 18 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS, IN 2020, (IN %), BY GENDER

FIGURE 19 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY TYPE, 2021

FIGURE 20 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 21 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 22 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 23 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY SOURCE, 2021

FIGURE 24 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY SOURCE, 2022-2029 (USD MILLION)

FIGURE 25 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY SOURCE, CAGR (2022-2029)

FIGURE 26 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY SOURCE, LIFELINE CURVE

FIGURE 27 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DRUGS, 2021

FIGURE 28 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DRUGS, 2022-2029 (USD MILLION)

FIGURE 29 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DRUGS, CAGR (2022-2029)

FIGURE 30 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DRUGS, LIFELINE CURVE

FIGURE 31 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY APPLICATION, 2021

FIGURE 32 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 33 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 34 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 35 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY ROUTE OF ADMINISTRATION, 2021

FIGURE 36 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY ROUTE OF ADMINISTRATION, 2022-2029 (USD MILLION)

FIGURE 37 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2022-2029)

FIGURE 38 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 39 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY END USER, 2021

FIGURE 40 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 41 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY END USER, CAGR (2022-2029)

FIGURE 42 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY END USER, LIFELINE CURVE

FIGURE 43 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 44 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 45 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 46 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 47 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: SNAPSHOT (2021)

FIGURE 48 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2021)

FIGURE 49 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 50 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 51 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY TYPE (2022-2029)

FIGURE 52 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: COMPANY SHARE 2021 (%)

View Detailed Information Right Arrow

Методология исследования

Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.

Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.

Доступна настройка

Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.

Часто задаваемые вопросы

The major countries operating in the Middle East and Africa Psychedelic Drugs Market are Saudi Arabia, Israel, Egypt, U.A.E, South Africa and Rest of Middle East and Africa.
Rising prevalence of mental depression and anxiety and availability of off label drugs are the significant factors flourishing the growth of the Middle East and Africa Psychedelic Drugs Market
The Middle East and Africa Psychedelic Drugs Market is to grow at a CAGR of 11.1% during the forecast by 2029.
The market value for Middle East and Africa Psychedelic Drugs Market is expected USD 27.94 million by 2029.